According to the Multiple Sclerosis Society of Canada, an estimated 100,000 Canadians are currently living with Multiple Sclerosis (MS). Currently, Canada has the highest rate of MS in the world.

MS is an auto-immune disease that inflames and damages the central nervous system by attacking myelin, the protective covering of nerves which are essential in transmitting nerve pulses. Depending on the severity of the disease, the degeneration of myelin can result in a variety of symptoms that include vision and bladder problems, lack of coordination, fatigue and cognitive impairment. There is no cure for MS and as yet researchers are not sure what causes the disease. However, the effects of medical cannabis on neuropathic pain, spasticity and sleep disturbance experienced by MS sufferers have been studied.

Click on the links below to view recently published studies on the effects of medical cannabis on symptoms associated with MS.

http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01379.x/full

http://www.tandfonline.com/doi/abs/10.1517/14656566.7.5.607

https://www.researchgate.net/publication/7576991_Rog_DJ_Nurmikko_TJ_Friede_T_Young_CA_Randomized_controlled_trial_of_cannabis-based_medicine_in_central_pain_in_multiple_sclerosis_Neurology_65_812-819

http://bmcneurol.biomedcentral.com/articles/10.1186/1471-2377-9-59

To find out about CannTrust’s medical cannabis strains, click here or call our Customer Care Team at 1-855-RX4-CANN (794-2266) from Monday-Friday, 8am-9pm (Eastern Standard Time). Alternately, you can email info@canntrust.ca  

About CannTrust

A federally regulated licensed producer, CannTrust™ brings more than 40 years of pharmacy and healthcare experience to the Medical Cannabis industry and applies this expertise to produce quality pharmaceutical-grade Medical Cannabis for patients in need. CannTrust™ is committed to research and innovation, to contributing to the growing body of evidence-based research regarding the use and efficacy of cannabis and to developing novel mechanisms that will make it easier for certain patients to take Medical Cannabis. The company supports ongoing patient education about Medical Cannabis, and has launched a compassionate use program to support patients with financial needs.

  • Our state-of-the-art facility provides pharmaceutical quality assurance and control combined with a patient centric approach to ensure we are producing quality products and delivering quality service to our customers.
  • Our 40,000 square foot state-of-the-art hydroponic facility provides continuous production of Medical Cannabis to address our patients’ needs.
  • We have built our own laboratory with advanced technology and equipment for testing and research on the medical use of cannabis.